Polymeric nanoparticles as delivery system for influenza virus glycoproteins

Journal of Controlled Release

Volumn 54, Issue 1, 1998, Pages 15-27

  Lemoine, D ^a   Preat V ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Hemagglutinin; Influenza virus; Nanoparticles; Poly(D,L lactide co glycolide)

Indexed keywords

AMPHOPHILE; HEMAGGLUTININ; INFLUENZA VACCINE; NANOPARTICLE; POLYGLACTIN; SOLVENT; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; EVAPORATION; FEMALE; HEMAGGLUTINATION; IMMUNODIFFUSION; INFLUENZA VIRUS; INTRANASAL DRUG ADMINISTRATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0345647081     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00241-1     Document Type: Article

References (43)

1. M.A. Strassburg, S. Greenland, F.J. Sorvillu, L.E. Lieb, L.A. Habel, Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports, Vaccine 4(1) (1986) 38-44.
2. C.W. Potter, J.S. Oxford, Determinants of immunity to influenza infection in man, Br. Med. Bull. 35 (1979) 69-75.
3. W.G. Laver, E.D. Kilbourne, Identification in a recombinant influenza virus of structural proteins derived from both parents, Virology 30(3) (1966) 493-501.
4. J.R. McGhee, J. Mestecky, M.T. Dertzbaugh, J.H. Eldridge, M. Hirasawa, H. Kiyono, The mucosal immune system: from fundamental concept to vaccine development, Vaccine 10(2) (1992) 75-88.
5. R.I. Walker, New strategies for using mucosal vaccination to achieve more effective immunization, Vaccine 12(5) (1994) 387-400.
6. C.F. Kuper, P.J. Koornstra, D.M. Hameleers, J. Biewenga, B.J. Split, A.M. Duijvestijn, P.J. van-Breda-Vriesman, T. Sminia, The role of nasopharynged lymphoid tissue, Immunol. Today 1(6) (1992) 219-224.
7. J.H. Eldridge, R.M. Gilley, J.K. Staas, A. Moldoveanu, J.A. Meulbrook, T.R. Tice, Biodegradable microspheres, a vaccine delivery system for oral immunization, Curr. Top. Microbiol. Immunol. 146 (1989) 59-66.
8. M. Higaki, M. Takenaga, R. Igarashi, C. Aizawa, Y. Mizushima, Microparticles resin enhanced immune response of intranasal influenza HA vaccine, Proc. Int. Symp. Contr. Rel. Bioact. Mater. 23 (1996) 163-164.
9. J. Mauduit, M. Vert, Les polymères à base d'acides lactiques et glycoliques et la délivrance contrôlée des principes actifs, S.T.P. Pharma Sci. 3(3) (1993) 197-212.
10. D. Lemoine, C. François, F. Kedzierewicz, V Préat, M. Hoffman, P. Maincent, Stability study of nanoparticles of poly(ε-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide), Biomaterials 17 (1996) 2191-2197.
11. J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley, T.R. Tice, Controlled vaccine release in the gut-associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches, J. Control. Release 11 (1990) 205-214.
12. E. Allémann, R. Gurny, E. Doelker, Drug-loaded nanoparticles-preparation methods and drug targeting issues, Eur. J. Biopharm. 39(5) (1993) 173-191.
13. S. Benita, Microencapsulation. Methods and industrial applications, Marcel Dekker, Inc., New York, Basel, Hong Kong, 1996.
14. R. Bodmeier, H. Chen, Indomethacin polymeric nanosuspensions prepared by microfluidization, J. Control. Release 12 (1990) 223-233.
15. M. Cavalier, J.P. Benoit, C. Thies, The formation and characterization of hydrocortisone-loaded poly(()-lactide)microspheres, J. Pharm. Pharmacol. 38 (1986) 249-253.
16. R. Bodmeier, J.W. Mc Ginity, The preparation and evaluation of drug containing poly(D,L-lactide) microspheres formed by solvent evaporation, Pharm. Res. 4 (1987) 465-471.
17. Y. Ogawa, M. Yamamoto, H. Okada, T. Yashiki, T. Shimamoto, A new technique to efficiently entrap leuprolide acetate into microcapsules of copoly(lactic/glycolic acid), Chem. Pharm. Bull. 36 (1988) 1095-1103.
18. H. Jeffery, S.S. Davis, D.T. O'Hagan, The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique, Pharm. Res. 10(3) (1993) 362-368.
19. P. Jani, G.W. Halbert, J. Langridge, A.T. Florence, The uptake and translocation of latex nanospheres and microspheres after administration to rats, J. Pharm. Pharmacol. 41 (1989) 809-812.
20. I.T. Schulze, The biologically active proteins of influenza virus: the hemagglutinin, in: E.D. Kilbourne (Ed.), The Influenza Virus and Influenza, Academic Press, New-York, San Francisco, London, 1975, pp. 53-83.
21. M.M. Bradford, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
22. W. Vanderhoff, M.S. El-Aasser, J. Ugelstad, Polymer emulsification process, U.S. Patent 4, 177, 177, 1979.
23. S.Y. Lin, W.H. Wu, Physical parameters and release behaviours of w/o/w multiple emulsions containing cosurfactants and different specific gravity of oils, Pharm. Acta Helv. 66(12) (1991) 342-347.
24. N.A. Armstrong, K.C. James, Understanding experimental design and interpretation in pharmaceutics, Ellis Horwood, New York, 1990.
25. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
26. R. C Switzer, C.R. Merril, S. Shifrin, A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels, Anal. Biochem. 98 (1979) 231-237.
27. M.S. Williams, R.E. Mayner, N.J. Daniel, M.A. Phelan, S.C. Rastogi, F.M. Bozeman, F.A. Ennis, New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single radial immunodiffusion, J. Biol. Stand. 8 (1980) 289-296.
28. R. Hawkes, E. Niday, J. Gordon, A dot-immunobinding assay for monoclonal and other antibodies, Anal. Biochem. 119 (1982) 142-147.
29. H. Towbin, T. Staehelin, J. Gordin, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications, Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354.
30. A. Sugiura, H. Yanagawa, C. Enomoto, M. Ueda, K. Tobita, N. Matsuzaki, D. Suzuki, R. Nakaya, I. Shigematsu, A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2/Hong Kong and B influenza virus, J. Infect. Dis. 122(6) (1970) 472-478.
31. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimato, N.M. Goeke, B.J. Olson, D.C. Klenk, Measurement of protein using bicinchoninic acid, Anal. Biochem. 150 (1985) 76-85.
32. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement, with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
33. G.K. Hirst, Quantitative determination of influenza virus ant antibodies by means of red cell agglutination, J. Exp. Med. 75 (1942) 49-64.
34. R.J. Slater, Radioisotopes in Biology. A practical approach, IRL Press, Oxford, 1990.
35. P.W. Chuppin, R.W. Compans, The structure of influenza virus, in: E.D. Kilbourne (Ed.), The Influenza Virus and Influenza, Academic Press, New York, San Francisco, London, 1975, pp. 15-51.
36. P.D. Scholes, A.G.A. Coombes, L. Illum, S. S Davis, M. Vert, M.C. Davies, The preparation of sub-200 nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery, J. Control. Release 25 (1993) 145-153.
37. H. Jeffery, S.S. Davis, D.T. O'Hagan, The preparation and characterisation of poly(lactide-co-glycolide) microparticles. I. Oil-in-water emulsion solvent evaporation, Int. J. Pharm. 77 (1991) 169-175.
38. M.J. Alonso, C. Losa, P. Calvo, J.L. Vila Jato, Approaches to improve the association of amikacin sulphate to poly-(alkylcyanoacrylate) nanoparticles, Int. J. Pharm. 68 (1991) 69-76.
39. H.J. Krause, A. Schwartz, P. Rohdewald, Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs, Int. J. Pharm. 27 (1985) 265-268.
40. J. Kreuter, P. P Speiser, In vitro studies of Poly(methylmethacrylate) adjuvants, J. Pharm. Sci. 65(11) (1976) 1624-1627.
41. N. Santiago, S. Milstein, T. Rivera, E. Garcia, T. Zaidi, H. Hong, D. Bucher, Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens, Pharm. Res. 10(8)(1993) 1243-1247.
42. Z. Moldoveanu, M. Novak, W.Q. Huang, R.M. Gilley, J.K. Staas, D. Schafer, R.W. Compans, J. Mestecky, Oral immunization with influenza virus in biodegradable microspheres, J. Infect. Dis. 167 (1993) 84-90.
43. M.J. Alonso, R.K. Gupta, C. Min, G.R. Siber, R. Langer, Biodegradable as controlled-release tetanus toxoid delivery systemsmicrospheres, Vaccine 12 (1994) 299-306.